Cargando…

Prognostic factors for mortality among patients with visceral leishmaniasis in East Africa: Systematic review and meta-analysis

BACKGROUND: Visceral leishmaniasis (VL) is a vector-borne disease that is deadly if left untreated. Understanding which factors have prognostic value may help to focus clinical management and reduce case fatality. However, information about prognostic factors is scattered and conflicting. We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abongomera, Charles, van Henten, Saskia, Vogt, Florian, Buyze, Jozefien, Verdonck, Kristien, van Griensven, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255612/ https://www.ncbi.nlm.nih.gov/pubmed/32413028 http://dx.doi.org/10.1371/journal.pntd.0008319

Ejemplares similares

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
por: Abongomera, Charles, et al.
Publicado: (2017)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study
por: Abongomera, Charles, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia
por: van Henten, Saskia, et al.
Publicado: (2021)

Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease
por: Boelaert, Marleen, et al.
Publicado: (2014)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2017)

Atypical Mucocutaneous Leishmaniasis Presentation Mimicking Rectal Cancer
por: Fikre, Helina, et al.
Publicado: (2023)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019)

Evaluation of the CL Detect Rapid Test in Ethiopian patients suspected for Cutaneous Leishmaniasis
por: van Henten, Saskia, et al.
Publicado: (2022)

Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
por: van Griensven, Johan, et al.
Publicado: (2014)

Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia
por: Buyze, Jozefien, et al.
Publicado: (2020)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
por: van Henten, Saskia, et al.
Publicado: (2023)

Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration
por: Mohammed, Rezika, et al.
Publicado: (2021)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
por: Boodman, Carl, et al.
Publicado: (2023)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2016)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
por: Dahl, Elin Hoffmann, et al.
Publicado: (2021)

Minimally Invasive Microbiopsies as an Improved Sampling Method for the Diagnosis of Cutaneous Leishmaniasis
por: Churiso, Gemechu, et al.
Publicado: (2020)

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
por: van Griensven, Johan, et al.
Publicado: (2014)

A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?
por: van Griensven, Johan, et al.
Publicado: (2014)

Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa
por: Kühne, Vera, et al.
Publicado: (2019)

Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2019)

Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Endris, Mengistu, et al.
Publicado: (2014)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
por: Diro, Ermias, et al.
Publicado: (2015)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
por: Diro, Ermias, et al.
Publicado: (2018)

Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia
por: De Weggheleire, Anja, et al.
Publicado: (2021)

Case Report: Atypical Presentation of Visceral Leishmaniasis: Two Cases from Northwest Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2021)

Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
por: Aderie, Endashaw M., et al.
Publicado: (2017)

Visceral Leishmaniasis Relapse in HIV Patients—A Role for Myeloid-Derived Suppressor Cells?
por: Van den Bergh, Rafael, et al.
Publicado: (2014)

Leishmaniasis Beyond East Africa
por: Jones, Caitlin M., et al.
Publicado: (2021)

Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2020)

HIV Prevalence by Race Co-Varies Closely with Concurrency and Number of Sex Partners in South Africa
por: Kenyon, Chris, et al.
Publicado: (2013)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
por: van Griensven, Johan, et al.
Publicado: (2018)

Visceral leishmaniasis in eastern Africa – current status
por: Reithinger, Richard, et al.
Publicado: (2007)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia
por: Vogt, Florian, et al.
Publicado: (2018)

The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis
por: Wasunna, Monique, et al.
Publicado: (2016)

Increases in condomless chemsex associated with HIV acquisition in MSM but not heterosexuals attending a HIV testing center in Antwerp, Belgium
por: Kenyon, Chris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rrnbs427tfd68ccao0u1fnmtuo